Table 5 Comparison between the proposed method and other reported methods for repaglinide determination in different matrices
Sample | Sample preparation | Method | LOD (ng/mL) | LOQ (ng/mL) | Refs. |
|---|---|---|---|---|---|
Human plasma | LLE | HPLC–UV | 10 | 20 | [2] |
Human plasma | LLE | ESI-LC–MS | 1 | 1 | [47] |
Human plasma | SPE | HPLC–UV | NR | 20 | [8] |
Monkey plasma | Protein precipitation | LC–MS/MS | NR | 1 | [6] |
Rabbit plasma | Protein precipitation | HPLC–UV | 18 | 55 | [48] |
Human urine | - | UPLC-MS/MS | 0.10 | 0.40 | [7] |
Human urine | Salting out | HILIC-MS/MS | NR | 2 | [10] |
Urine | SPE | LC–MS/MS | 5 | NR | [11] |
Tablet | Filtration and dilution | Ion pair HPLC–UV | 27 | 81 | [49] |
Tablet | Filtration and dilution | HPLC–UV | NR | 100 | [50] |
Tablet | Filtration and dilution | HPLC–UV | 100 | 310 | [51] |
Tablet | Filtration and dilution | HPLC–UV | 278 | 840 | [52] |
Tap water | vortex assisted-DLLME | HPLC–UV | 0.40 | 1 | This work |